Reviewed,
UniProtKB/Swiss-Prot Q07820 (MCL1_HUMAN)
Last modified
November 25, 2008.
Version 89.
History...
Clusters with 100%,
90%,
50% identity |
Documents (7) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Induced myeloid leukemia cell differentiation protein Mcl-1 Alternative name(s): Bcl-2-related protein EAT/mcl1 mcl1/EAT | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 350 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Involved in the regulation of apoptosis versus cell survival, and in the maintenance of viability but not of proliferation. Mediates its effects by interactions with a number of other regulators of apoptosis. Isoform 1 inhibits apoptosis while isoform 2 promotes it. |
| Subunit structure | Interacts with BAD, BOK, BIK and BFM By similarity. Interacts with PMAIP1. Isoform 1 interacts with BAX, BAK1, TPT1 and BCL2L11. Heterodimer of isoform 1 and isoform 2. Homodimers of isoform 1 or isoform 2 are not detected. Isoform 2 does not interact with pro-apoptototic BCL2-related proteins. |
| Subcellular location | Membrane; Single-pass membrane proteinPotential. Cytoplasm. Mitochondrion. Nucleus › nucleoplasm. Note= Cytoplasmic, associated with mitochondria. |
| Induction | Expression increases early during phorbol-ester induced differentiation along the monocyte/macrophage pathway in myeloid leukemia cell lines ML-1. Rapidly up-regulated by CSF2 in ML-1 cells. Up-regulated by heat-shock induced differentiation. Expression increases early during retinoic acid-induced differentiation. |
| Post-translational modification | Cleaved by CASP3 during apoptosis. In intact cells cleavage occurs preferentially after Asp-127, yielding a pro-apoptotic 28 kDa C-terminal fragment. Rapidly degraded in the absence of phosphorylation on Thr-163 in the PEST region. Phosphorylated on Thr-163. Treatment with taxol or okadaic acid induces phosphorylation on additional sites. |
| Sequence similarities | Belongs to the Bcl-2 family. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| BAK1 | Q16611 | 3 | EBI-1003422,EBI-519866 | |
| BBC3 | Q9BXH1 | 1 | EBI-1003422,EBI-519884 | |
| BID | P55957 | 1 | EBI-1003422,EBI-519672 | |
| BIK | Q13323 | 1 | EBI-1003422,EBI-700794 | |
| bim-alpha1 | Q8WYM1 | 1 | EBI-1003422,EBI-1002160 | |
| Bmf | Q91ZE9 | 1 | EBI-1003422,EBI-708032 | From a different organism. |
| PMAIP1 | Q13794 | 1 | EBI-1003422,EBI-707392 | |
| Pmaip1 | Q9JM54 | 1 | EBI-1003422,EBI-709183 | From a different organism. |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q07820-1) Also known as: MCL1L; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q07820-2) Also known as: Delta S; MCL-1S; TM; The sequence of this isoform differs from the canonical sequence as follows: 231-271: MLRKLDIKNE...GRIVTLISFG → WVCGVLPCRG...FGISNKIALL 272-350: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 350 | 350 | Induced myeloid leukemia cell differentiation protein Mcl-1 | PRO_0000143080 | ||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||
| Transmembrane | 328 – 348 | 21 | Potential | |||||||||||||||||||||||
| Region | 104 – 175 | 72 | PEST-like | |||||||||||||||||||||||
| Motif | 209 – 223 | 15 | BH3 | |||||||||||||||||||||||
| Motif | 252 – 272 | 21 | BH1 | |||||||||||||||||||||||
| Motif | 304 – 319 | 16 | BH2 | |||||||||||||||||||||||
Sites | ||||||||||||||||||||||||||
| Site | 127 – 128 | 2 | Cleavage; by caspase-3 | |||||||||||||||||||||||
| Site | 157 – 158 | 2 | Cleavage; by caspase-3 | |||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||
| Modified residue | 121 | 1 | Phosphoserine | |||||||||||||||||||||||
| Modified residue | 163 | 1 | Phosphothreonine; by MAPK | |||||||||||||||||||||||
| Cross-link | 5 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) | ||||||||||||||||||||||||
| Cross-link | 40 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) | ||||||||||||||||||||||||
| Cross-link | 136 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) | ||||||||||||||||||||||||
| Cross-link | 194 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) | ||||||||||||||||||||||||
| Cross-link | 197 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) | ||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||
| Alternative sequence | 231 – 271 | 41 | MLRKL…LISFG → WVCGVLPCRGPRRWHQECAA GFCRCCWSRSWFGISNKIAL L in isoform 2. | VSP_000532 | ||||||||||||||||||||||
| Alternative sequence | 272 – 350 | 79 | Missing in isoform 2. | VSP_000533 | ||||||||||||||||||||||
| Natural variant | 173 | 1 | E → D: dbSNP rs2737820. | VAR_024021 | ||||||||||||||||||||||
| Natural variant | 227 | 1 | A → V: dbSNP rs11580946. | VAR_024022 | ||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||
| Mutagenesis | 5 | 1 | K → R: Reduced ubiquitination | |||||||||||||||||||||||
| Mutagenesis | 40 | 1 | K → R: Reduced ubiquitination | |||||||||||||||||||||||
| Mutagenesis | 127 | 1 | D → A: Abolishes formation of 28 and 17 kDa cleavage products by CASP3. Abolishes cleavage by caspase-3; when associated with A-157 | |||||||||||||||||||||||
| Mutagenesis | 136 | 1 | K → R: Reduced ubiquitination | |||||||||||||||||||||||
| Mutagenesis | 157 | 1 | D → A: Abolishes formation of 23 and 21 kDa cleavage products by CASP3. Abolishes cleavage by caspase-3; when associated with A-127 | |||||||||||||||||||||||
| Mutagenesis | 162 | 1 | S → A: No effect | |||||||||||||||||||||||
| Mutagenesis | 163 | 1 | T → A: Abolishes phosphorylation by MAPK. No effect on phosphorylation induced by okadaic acid or taxol | |||||||||||||||||||||||
| Mutagenesis | 194 | 1 | K → R: Reduced ubiquitination | |||||||||||||||||||||||
| Mutagenesis | 197 | 1 | K → R: Reduced ubiquitination | |||||||||||||||||||||||
| Mutagenesis | 208 | 1 | K → R: No effect on ubiquitination | |||||||||||||||||||||||
| Mutagenesis | 234 | 1 | K → R: No effect on ubiquitination | |||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||
| Helix | 173 – 191 | 19 | ||||||||||||||||||||||||
| Helix | 204 – 221 | 18 | ||||||||||||||||||||||||
| Helix | 225 – 235 | 11 | ||||||||||||||||||||||||
| Helix | 244 – 253 | 10 | ||||||||||||||||||||||||
| Helix | 254 – 256 | 3 | ||||||||||||||||||||||||
| Helix | 261 – 281 | 21 | ||||||||||||||||||||||||
| Helix | 288 – 301 | 14 | ||||||||||||||||||||||||
| Helix | 303 – 308 | 6 | ||||||||||||||||||||||||
| Turn | 309 – 311 | 3 | ||||||||||||||||||||||||
| Helix | 312 – 318 | 7 | ||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2." Kozopas K.M., Yang T., Buchan H.L., Zhou P., Craig R.W. Proc. Natl. Acad. Sci. U.S.A. 90:3516-3520(1993) [PubMed: 7682708] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT ASP-173. Tissue: Myeloid leukemia cell. |
| [2] | "Induction of mcl1/EAT, Bcl-2 related gene, by retinoic acid or heat shock in the human embryonal carcinoma cells, NCR-G3." Umezawa A., Maruyama T., Inazawa J., Imai S., Takano T., Hata J. Cell Struct. Funct. 21:143-150(1996) [PubMed: 8790944] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INDUCTION. |
| [3] | "Functional analysis of the human MCL-1 gene." Akgul C., Turner P.C., White M.R.H., Edwards S.W. Cell. Mol. Life Sci. 57:684-691(2000) [PubMed: 11130466] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). |
| [4] | "Exon skipping in Mcl-1 results in a Bcl-2 homology domain 3 only gene product that promotes cell death." Bingle C.D., Craig R.W., Swales B.M., Singleton V., Zhou P., Whyte M.K.B. J. Biol. Chem. 275:22136-22146(2000) [PubMed: 10766760] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1 AND 2), VARIANT ASP-173, FUNCTION. Tissue: Myeloid leukemia cell and Neuroblastoma. |
| [5] | "MCL-1S, a splicing variant of the antiapoptotic BCL-2 family member MCL-1, encodes a proapoptotic protein possessing only the BH3 domain." Bae J., Leo C.P., Hsu S.Y., Hsueh A.J.W. J. Biol. Chem. 275:25255-25261(2000) [PubMed: 10837489] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), INTERACTION WITH BAX; BAK1; BCL2L11 AND BETWEEN ISOFORMS 1 AND 2. |
| [6] | "Cloning of human full-length CDSs in BD Creator(TM) system donor vector." Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., Phelan M., Farmer A. Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). |
| [7] | "NIEHS-SNPs, environmental genome project, NIEHS ES15478, Department of Genome Sciences, Seattle, WA (URL: http://egp.gs.washington.edu)." Livingston R.J., Rieder M.J., Shaffer T., Bertucci C., Baier C.N., Rajkumar N., Willa H.T., Daniels M., Downing T.K., Stanaway I.B., Nguyen C.P., Gildersleeve H., Cassidy C.M., Johnson E.J., Swanson J.E., McFarland I., Yool B., Park C., Nickerson D.A. Submitted (JUN-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT VAL-227. |
| [8] | "The DNA sequence and biological annotation of human chromosome 1." Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K. Bentley D.R.Nature 441:315-321(2006) [PubMed: 16710414] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [9] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Mammary gland and Placenta. |
| [10] | "Acute myeloid leukemia possessing jumping translocation is related to highly elevated levels of EAT/mcl-1, a Bcl-2 related gene with anti-apoptotic functions." Okita H., Umezawa A., Fukuma M., Hata J. Leuk. Res. 24:73-77(2000) [PubMed: 10634649] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 182-289 (ISOFORM 1), VARIANT VAL-227. Tissue: Ewing sarcoma. |
| [11] | "Mcl-1 is required for Akata6 B-lymphoma cell survival and is converted to a cell death molecule by efficient caspase-mediated cleavage." Michels J., O'Neill J.W., Dallman C.L., Mouzakiti A., Habens F., Brimmell M., Zhang K.Y.J., Craig R.W., Marcusson E.G., Johnson P.W.M., Packham G. Oncogene 23:4818-4827(2004) [PubMed: 15122313] [Abstract] Cited for: PROTEIN SEQUENCE OF N-TERMINUS OF FRAGMENTS OBTAINED BY CASPASE CLEAVAGE, MUTAGENESIS OF ASP-127 AND ASP-157. |
| [12] | "Mcl-1 is an immediate-early gene activated by the granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling pathway and is one component of the GM-CSF viability response." Chao J.-R., Wang J.-M., Lee S.-F., Peng H.-W., Lin Y.-H., Chou C.-H., Li J.-C., Huang H.-M., Chou C.-K., Kuo M.-L., Yen J.J.-Y., Yang-Yen H.-F. Mol. Cell. Biol. 18:4883-4898(1998) [PubMed: 9671497] [Abstract] Cited for: INDUCTION. |
| [13] | "Physical and functional interaction between myeloid cell leukemia 1 protein (MCL1) and fortilin. The potential role of MCL1 as a fortilin chaperone." Zhang D., Li F., Weidner D., Mnjoyan Z.H., Fujise K. J. Biol. Chem. 277:37430-37438(2002) [PubMed: 12149273] [Abstract] Cited for: INTERACTION WITH TPT1, SUBCELLULAR LOCATION. |
| [14] | "Phosphorylation and inactivation of myeloid cell leukemia 1 by JNK in response to oxidative stress." Inoshita S., Takeda K., Hatai T., Terada Y., Sano M., Hata J., Umezawa A., Ichijo H. J. Biol. Chem. 277:43730-43734(2002) [PubMed: 12223490] [Abstract] Cited for: PHOSPHORYLATION AT SER-121 AND THR-163. |
| [15] | "Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex." Leu J.I.-J., Dumont P., Hafey M., Murphy M.E., George D.L. Nat. Cell Biol. 6:443-450(2004) [PubMed: 15077116] [Abstract] Cited for: INTERACTION WITH BAK, SUBCELLULAR LOCATION. |
| [16] | "MCL1 is phosphorylated in the PEST region and stabilized upon ERK activation in viable cells, and at additional sites with cytotoxic okadaic acid or taxol." Domina A.M., Vrana J.A., Gregory M.A., Hann S.R., Craig R.W. Oncogene 23:5301-5315(2004) [PubMed: 15241487] [Abstract] Cited for: PHOSPHORYLATION AT THR-163, MUTAGENESIS OF SER-162 AND THR-163. |
| [17] | "Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis." Zhong Q., Gao W., Du F., Wang X. Cell 121:1085-1095(2005) [PubMed: 15989957] [Abstract] Cited for: UBIQUITINATION, MUTAGENESIS OF LYS-5; LYS-40; LYS-136; LYS-194; LYS-197; LYS-208 AND LYS-234. |
| [18] | "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis." Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III J. Proteome Res. 7:1346-1351(2008) [PubMed: 18220336] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-163, MASS SPECTROMETRY. |
| [19] | "Structural insights into the degradation of Mcl-1 induced by BH3 domains." Czabotar P.E., Lee E.F., van Delft M.F., Day C.L., Smith B.J., Huang D.C.S., Fairlie W.D., Hinds M.G., Colman P.M. Proc. Natl. Acad. Sci. U.S.A. 104:6217-6222(2007) [PubMed: 17389404] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.55 ANGSTROMS) OF 151-307 IN COMPLEXES WITH PMAIP1 AND BCL2L11. |
| [20] | "X-ray crystal structure of human MCL-1 in complex with BIM BH3." Bare E., Grant R.A., Keating A.E. Submitted (JUN-2007) to the PDB data bank Cited for: X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 172-327 IN COMPLEX WITH BCL2L11. |
| + | Additional computationally mapped references. |

Clusters with